These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 17550963

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP.
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption.
    Ledger GA, Burritt MF, Kao PC, O'Fallon WM, Riggs BL, Khosla S.
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3304-10. PubMed ID: 7593443
    [Abstract] [Full Text] [Related]

  • 6. Circasemidian rather than circadian variation of circulating osteoprotegerin in clinical health.
    Tarquini R, Mazzoccoli G, Dolenti S, Gaudiano P, Comuni C, Laffi G, Perfetto F, Otsuka K, Cornélissen G, Halberg F.
    Biomed Pharmacother; 2005 Oct; 59 Suppl 1(Suppl 1):S225-8. PubMed ID: 16275499
    [Abstract] [Full Text] [Related]

  • 7. The effect of timing of teriparatide treatment on the circadian rhythm of bone turnover in postmenopausal osteoporosis.
    Luchavova M, Zikan V, Michalska D, Raska I, Kubena AA, Stepan JJ.
    Eur J Endocrinol; 2011 Apr; 164(4):643-8. PubMed ID: 21289031
    [Abstract] [Full Text] [Related]

  • 8. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
    Chiba Y, Onouchi T, Ikeda T, Adachi J, Tamura Y, Horiuchi T.
    Gerontology; 2009 Apr; 55(3):275-80. PubMed ID: 19158438
    [Abstract] [Full Text] [Related]

  • 9. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism.
    Ahmad AM, Thomas J, Clewes A, Hopkins MT, Guzder R, Ibrahim H, Durham BH, Vora JP, Fraser WD.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2860-8. PubMed ID: 12788900
    [Abstract] [Full Text] [Related]

  • 10. Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis.
    Fraser WD, Logue FC, Christie JP, Gallacher SJ, Cameron D, O'Reilly DS, Beastall GH, Boyle IT.
    Osteoporos Int; 1998 Jun; 8(2):121-6. PubMed ID: 9666934
    [Abstract] [Full Text] [Related]

  • 11. Circadian variation in ionized calcium and intact parathyroid hormone: evidence for sex differences in calcium homeostasis.
    Calvo MS, Eastell R, Offord KP, Bergstralh EJ, Burritt MF.
    J Clin Endocrinol Metab; 1991 Jan; 72(1):69-76. PubMed ID: 1986029
    [Abstract] [Full Text] [Related]

  • 12. Circadian rhythm and pulsatility of parathyroid hormone secretion in man.
    Herfarth K, Schmidt-Gayk H, Graf S, Maier A.
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):511-9. PubMed ID: 1286521
    [Abstract] [Full Text] [Related]

  • 13. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
    Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Biondi B, Iorio S, Giustina A, Amato G, Carella C.
    J Bone Miner Res; 2005 Mar; 20(3):480-6. PubMed ID: 15746993
    [Abstract] [Full Text] [Related]

  • 14. Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis.
    Piatek S, Adolf D, Wex T, Halangk W, Klose S, Westphal S, Amthauer H, Winckler S.
    Maturitas; 2013 Apr; 74(4):363-8. PubMed ID: 23391500
    [Abstract] [Full Text] [Related]

  • 15. Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study.
    Giusti M, Cecoli F, Fazzuoli L, De Franchis V, Ceresola E, Ferone D, Mussap M, Minuto F.
    Metabolism; 2007 May; 56(5):699-707. PubMed ID: 17445547
    [Abstract] [Full Text] [Related]

  • 16. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG, Kim JH, Kim JY, Ku SY, Jee BC, Suh CS, Kim SH, Choi YM.
    Menopause; 2007 May; 14(5):913-8. PubMed ID: 17667143
    [Abstract] [Full Text] [Related]

  • 17. Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized-controlled study on the effects of loop- and thiazide-diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women.
    Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L.
    Eur J Clin Invest; 2001 Sep; 31(9):764-72. PubMed ID: 11589718
    [Abstract] [Full Text] [Related]

  • 18. Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis.
    Dovio A, Generali D, Tampellini M, Berruti A, Tedoldi S, Torta M, Bonardi S, Tucci M, Allevi G, Aguggini S, Bottini A, Dogliotti L, Angeli A.
    Osteoporos Int; 2008 Jan; 19(1):113-7. PubMed ID: 17703272
    [Abstract] [Full Text] [Related]

  • 19. Cortical bone status is associated with serum osteoprotegerin concentration in men: the STRAMBO study.
    Szulc P, Hawa G, Boutroy S, Vilayphiou N, Schoppet M, Chapurlat R, Hofbauer LC.
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2216-26. PubMed ID: 21565793
    [Abstract] [Full Text] [Related]

  • 20. Circadian concentrations of free testosterone, selected markers of bone metabolism, osteoprotegerin and its ligand sRANKL in obese postmenopausal women.
    Ostrowska Z, Kos-Kudła B, Marek B, Kajdaniuk D, Wołkowska-Pokrywa K.
    Postepy Hig Med Dosw (Online); 2011 Oct 11; 65():658-67. PubMed ID: 22100799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.